13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 3 managers

Reported value

$5.16M

Holders

3

+0 new · −0 exited

Holders’ est. mark

$631.4K

Price effect on 3 books still in the name

Largest holder

$4.44M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC122.8K$4.44M$541.8KAdded$1.05M
Henshaw Capital LLC19.6K$710.2K$89.1KAdded$152.1K
DANSKE BANK A/S100$3.62K$498Cut−$12K

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.